SOL Group (SOL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
11 Jun, 2026Executive summary
Net sales reached €874.1 million in H1 2025, up 12.1% year-over-year, with growth in both Italy (+9.7%) and internationally (+13.7%).
Net profit increased 11.5% to €83.5 million, representing 9.6% of turnover.
Gross operating margin (EBITDA) was €220.8 million (25.3% of sales), up 9.7% from H1 2024.
Five acquisitions were completed across different business areas since the start of the year.
Workforce grew to over 7,400 employees from 7,015 a year earlier.
Financial highlights
Revenues from sales and services: €874.1 million (H1 2025) vs €779.6 million (H1 2024).
EBITDA: €220.8 million (25.3% margin) vs €201.3 million (25.8% margin) in H1 2024.
Operating result (EBIT): €134.9 million (15.4% margin) vs €122.2 million (15.7% margin) in H1 2024.
Net profit: €83.5 million (EPS €0.921) vs €74.9 million (EPS €0.826) in H1 2024.
Cash flow from operations rose to €169.8 million, and capital expenditure totaled €116.3 million.
Outlook and guidance
Management expects continued growth in H2 2025, focusing on further investments, acquisitions, and innovation projects.
Objective to consolidate strong sales and maintain healthy profitability amid economic uncertainty.
Latest events from SOL Group
- Q1 2026 sales grew 7.2% year-over-year, led by Home Care and international expansion.SOL
Q1 2026 - Double-digit sales growth, higher profitability, and strategic acquisitions drive robust results.SOL
Q4 2025 - Revenue rose 11.1% to €1,311.6M, with robust growth in both core divisions.SOL
Q3 2025 - Sales up 6% to €779.6M; home care growth offsets technical gas decline, net profit down.SOL
H1 2024 - 2023 sales reached €1.49B, with strong margins and leading sustainability achievements.SOL
Corporate Presentation - Q1 2025 sales rose 12.7% year-over-year, led by robust growth in both core divisions.SOL
Q1 2025 - SOL Group delivered solid growth in sales and profit, led by Home Care and international markets.SOL
H2 2024